Loading…
Autonomix Medical, Inc. is projected to decline to $5.77 by 2027, a -12% move from its current price of $6.57. AMIX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $6.27 | $6.57 | $6.88 | +0.01% |
| Jul 14 | $6.16 | $6.57 | $7.01 | +0.02% |
| Jul 15 | $6.07 | $6.57 | $7.12 | +0.03% |
| Jul 16 | $5.99 | $6.57 | $7.21 | +0.03% |
| Jul 17 | $5.93 | $6.57 | $7.29 | +0.04% |
| Jul 18 | $5.87 | $6.57 | $7.36 | +0.05% |
| Jul 19 | $5.82 | $6.57 | $7.43 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.82 | $6.57 | $7.43 | +0.06% |
| Week 2 | $5.53 | $6.58 | $7.82 | +0.12% |
| Week 3 | $5.33 | $6.58 | $8.13 | +0.18% |
| Week 4 | $5.16 | $6.59 | $8.41 | +0.25% |
| Week 5 | $5.01 | $6.59 | $8.66 | +0.31% |
| Week 6 | $4.89 | $6.59 | $8.89 | +0.37% |
| Week 7 | $4.78 | $6.60 | $9.12 | +0.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Autonomix Medical, Inc. (AMIX) is a development stage medical device company in the Healthcare sector. It focuses on advancing technologies for sensing and treating disorders of the nervous system, including a catheter-based system with microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.
The company develops technology for pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular and other nerve-related disorders. It was incorporated in 2014 and is headquartered in The Woodlands, Texas.
AMIX operates in the healthcare device space with a focus on nervous system sensing and treatment technologies, positioning itself as a development stage enterprise within this field.
AMIX is currently priced at $6.43 with a market capitalization of $3.49M. It ranks 5256 in market size.
The 30-day range is $4.57 to $9.05, and the current price sits within this band. The price is below the 50-day simple moving average ($7.65) and well below the 200-day simple moving average ($12.70).
Forecast details show a breadth of outcomes: 2026 is Neutral with avg $6.43 and ROI 0; 2031-2050 generally trend higher with bullish years such as 2031 (avg $8.22, ROI 27.9) and 2050 (avg $19.20, ROI 198.7).
The stock exhibits high risk as indicated by an annualized volatility of 100%, underscoring the potential for wide price swings.
A major floor 95.7% below — a decisive break under it would weaken the trend.
The nearest floor, 12.9% below — buyers have tended to step in here.
The nearest ceiling, 32.6% above — a clean break opens room to run.
A major ceiling 78.8% above — clearing it would confirm fresh momentum.
Key AMIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AMIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.56 | Buy | $6.49 | Buy |
| MA 10 | $6.39 | Buy | $6.06 | Buy |
| MA 20 | $4.38 | Buy | $4.85 | Buy |
| MA 50 | $1.98 | Buy | $2.88 | Buy |
| MA 100 | $1.19 | Buy | $1.85 | Buy |
| MA 200 | $0.9891 | Buy | $1.95 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.94 | Sell |
| Stoch RSI (14) | 50.85 | Neutral |
| CCI (20) | 52.26 | Neutral |
| Williams %R (14) | -11.16 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | -10.59 | Sell |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 88.84 | Sell |
| TRIX (15) | 11.30 | Buy |
| Awesome (5,34) | 3.82 | Buy |
| Ultimate (7,14,28) | 67.16 | Neutral |
| Momentum (10) | 0.19 | Buy |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 6.53 | Buy |
| ADX (14) | 40.01 | Buy |
| ATR (14) | 0.38 | Info |
Near-term sentiment is BEARISH.
RSI14 is 40, and the price trades below both the SMA50 ($7.65) and the SMA200 ($12.70), suggesting a bearish intermediate/longer-term tilt.
Key near-term support is at $5.72 and resistance at $8.78, with the 30-day range spanning $4.57 to $9.05.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.72 | $6.57 | $8.69 | 0% | Neutral | |
| $4.30 | $5.77 | $8.34 | -12% | Neutral | |
| $4.40 | $6.22 | $9.51 | -5% | Neutral | |
| $3.82 | $5.63 | $9.00 | -14% | Neutral | |
| $4.43 | $6.80 | $11.27 | +3% | Neutral | |
| $5.16 | $8.21 | $14.04 | +25% | Bullish | |
| $4.86 | $7.99 | $14.06 | +22% | Bullish | |
| $4.72 | $8.01 | $14.45 | +22% | Bullish | |
| $4.06 | $7.12 | $13.15 | +8% | Neutral | |
| $3.74 | $6.76 | $12.75 | +3% | Neutral | |
| $4.67 | $9.77 | $20.08 | +49% | Bullish | |
| $8.91 | $19.80 | $45.55 | +201% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.72 | $6.57 | $8.29 | +0.00% |
| August 2026 | $5.77 | $6.94 | $8.67 | +5.63% |
| September 2026 | $5.44 | $6.62 | $8.42 | -4.58% |
| October 2026 | $5.35 | $6.58 | $8.49 | -0.65% |
| November 2026 | $5.47 | $6.79 | $8.88 | +3.25% |
| December 2026 | $5.25 | $6.57 | $8.69 | -3.25% |
Click any year to see its month-by-month AMIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AMIX to range from $5.72 to $8.69 through 2026. The $6.57 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AMIX price prediction for 2027 points to an average of $5.77 (low $4.30, high $8.34) — a potential decline of -12% on today's $6.57. A consolidation phase looks the most probable path here.
In 2028, AMIX is projected to trade between $4.40 and $9.51, averaging $6.22 — a potential decline of -5% from today's $6.57. That is up +8% on the projected 2027 average. Price action looks broadly range-bound.
Autonomix Medical, Inc.'s 2029 outlook centres on $5.63, within a $3.82 to $9.00 range. That is -10% versus the projected 2028 average. That marks a -14% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, AMIX could reach as high as $11.27, with a base case around $6.80 and support toward $4.43 — roughly +3% from $6.57. Price action looks broadly range-bound.
Expect AMIX to range from $5.16 to $14.04 through 2031. The $8.21 average target implies a +25% move from current prices. That is up +21% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The AMIX price prediction for 2032 points to an average of $7.99 (low $4.86, high $14.06) — a potential gain of +22% on today's $6.57. Momentum favours further upside here.
In 2033, AMIX is projected to trade between $4.72 and $14.45, averaging $8.01 — a potential gain of +22% from today's $6.57. That is up 0% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Autonomix Medical, Inc.'s 2034 outlook centres on $7.12, within a $4.06 to $13.15 range. That is -11% versus the projected 2033 average. That marks a +8% change versus current levels. Price action looks broadly range-bound.
By 2035, AMIX could reach as high as $12.75, with a base case around $6.76 and support toward $3.74 — roughly +3% from $6.57. A consolidation phase looks the most probable path here.
Expect AMIX to range from $4.67 to $20.08 through 2040. The $9.77 average target implies a +49% move from current prices. That is up +44% on the projected 2035 average. Momentum favours further upside here.
The AMIX price prediction for 2050 points to an average of $19.80 (low $8.91, high $45.55) — a potential gain of +201% on today's $6.57. Buyers look set to stay in control over this stretch.
Investing $1,000 in AMIX today (≈ 152.207002 AMIX) could be worth
$3,014.14
+$2,014.14 (+201%) by 2050 · US Dollar
Based on the average projected AMIX price of $19.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AMIXwould be worth at today's price.
$1,000 invested in AMIX on Jul 10, 2025 (≈ 662.25166 AMIX) would be worth
$4,350.99
+$3,350.99 (+335.1%) today · 4.35× · US Dollar
Based on a AMIX entry price of $1.51 vs. today's $6.57.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.43 | $1,021.77 | +2.2% |
| 1 month ago | $0.379 | $17,335.09 | +1633.5% |
| 3 months ago | $0.38 | $17,289.47 | +1628.9% |
| 6 months ago | $0.505 | $13,009.9 | +1201.0% |
| 1 year ago | $1.51 | $4,350.99 | +335.1% |
| All time (2.4y) ago | $101.4 | $64.79 | -93.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AMIX forecast.
Our base-case forecast reaches $13.00 around 2050.
Implied market cap at $13.00: $7.06M
Across the multi-year forecast, the path shows a transition from mixed near-term results to more pronounced upside in later years.
2026 is a Neutral year with avg $6.43 and ROI 0, followed by years with negative momentum such as 2027 (avg $5.56, ROI -13.5) and 2029 (avg $5.23, ROI -18.6).
From 2030 onward, the outlook improves: 2030 avg $6.63 ROI 3.2; 2031 avg $8.22 ROI 27.9; 2032 avg $7.73 ROI 20.3; 2033 avg $7.86 ROI 22.2; 2034 avg $6.86 ROI 6.7.
The bullish trajectory continues into later years, with 2040 avg $9.48 ROI 47.5 and 2050 avg $19.20 ROI 198.7, signaling substantial upside potential alongside ongoing uncertainty.
Tap a question to reveal the answer.
Avg $6.63, min $4.14, max $11.41, ROI 3.2, sentiment NEUTRAL.
Near-term shows 2026 avg $6.43 with ROI 0; longer horizon includes positive ROI in years like 2031 (27.9%) and 2050 (198.7%), but some years show negative ROI (2027 -13.5%, 2029 -18.6%). These numbers are forecasts and not guarantees.
The forecast lists a 2040 max of $20.55 and a 2050 max of $44.17, indicating a possibility of crossing the $20 mark in the longer term.
Bearish sentiment is indicated currently; near-term negative momentum appears in forecasts such as 2027 ROI -13.5% and 2029 ROI -18.6%, with some years showing smaller losses.
Current price is $6.43 and market cap is $3.49M. It ranks 5256.
Autonomix Medical, Inc. Community Discussion
0Share your Autonomix Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.